Showing results (681-690 of 700) with videos related to
Sort By:
Pageof 70
Bioorganic & Medicinal Chemistry Letters|September 3, 2011
Discovery of a highly potent series of TLR7 agonistsPeter Jones, David C Pryde, Thien-Duc Tran, et al.The American Journal of Pathology|October 2, 2012
Large oncosomes in human prostate cancer tissues and in the circulation of mice with metastatic diseaseDolores Di Vizio, Matteo Morello, Andrew C Dudley, et al.Vaccines|April 30, 2021
Differentiation of Capripox Viruses by Nanopore SequencingKamal H Eltom, Anna Christina Althoff, Sören Hansen, et al.Transfusion|April 18, 2023
Comparison of platelet quality and function across apheresis collection platformsKimberly A Thomas, Amudan J Srinivasan, Colby McIntosh, et al.Bioorganic & Medicinal Chemistry Letters|February 15, 2011
Discovery of potent and orally bioavailable heterocycle-based cannabinoid CB1 receptor agonistsTakao Kiyoi, Julia M Adam, John K Clark, et al.La Revue De Medecine Interne|June 19, 2012
[Crushing drugs in geriatric units: an "handicraft" practice with frequent errors which imposed recommendations]M Caussin, W Mourier, S Philippe, et al.Biorxiv : the Preprint Server for Biology|December 18, 2023
Integrated omics analysis unveils a DNA damage response to neurogenic injuryAli Hashemi Gheinani, Bryan S Sack, Alex Bigger-Allen, et al.JCI Insight|May 8, 2025
Multiomics analysis unveils an inosine-sensitive DNA damage response in neurogenic bladder after spinal cord injuryAli Hashemi Gheinani, Bryan S Sack, Alexander Bigger-Allen, et al.Proceedings of the National Academy of Sciences of the United States of America|June 19, 2019
Small-molecule allosteric activators of PDE4 long form cyclic AMP phosphodiesterasesFaisa Omar, Jane E Findlay, Gemma Carfray, et al.Bioorganic & Medicinal Chemistry Letters|March 23, 2011
Design and optimisation of orally active TLR7 agonists for the treatment of hepatitis C virus infectionThien-Duc Tran, David C Pryde, Peter Jones, et al.Pageof 70